3 completed, 1 terminated. .
Follow Angle plc: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Characterization of Circulating Tumor Cells (CTCs) in High Risk and Early Metastatic Prostate Cancer Patients Using Parsortix® System Blood collection - High Risk Prostate Carcinoma, Biochemically Recurrent Prostate Carcinoma | Terminated | Angle plc | 9 | 2022-07-05 | 2023-09-05 | |
| Harvest of CTCs From MBC Patients Using the Parsortix™ PC1 System Blood draw - Healthy Volunteers, Breast Cancer, Metastatic | Completed | Angle plc | 421 | 2018-03-29 | 2023-06-05 | |
| Evaluation of Multiple Biomarkers to Estimate Risk of Ovarian Cancer in Patients With a Pelvic Mass. Pelvic imaging, Blood draw, laparotomy or laparoscopy - Ovarian Neoplasms | Completed | Angle plc | 204 | 2016-07-14 | 2018-11-09 | |
| Evaluation of Multiple Protein and Molecular Biomarkers to Estimate Risk of Cancer in Gynecology Patients Presenting With a Pelvic Mass. Pelvic imaging, Blood draw, Imaging guided biopsy, surgical biopsy or surgical excision - Ovarian Neoplasms | Completed | Angle plc | 200 | 2016-06-30 | 2023-06-05 |
Neoplastic Cells, Circulating (2) · Ovarian Neoplasms (2) · Breast Neoplasms (1) · Neoplasm Metastasis (1) · Prostatic Neoplasms (1)
Blood Specimen Collection (4) · Magnetic Resonance Spectroscopy (2) · Phlebotomy (2) · Data Collection (1) · Image-Guided Biopsy (1) · Laparoscopy (1) · Laparotomy (1)
United States (3) · Austria (1) · Germany (1)
Jose G Moreno, MD (1) · Naoto Ueno, MD, PhD (1) · Richard G Moore, MD (1) · Shane Booth, Ph.D. (1)